- 专利标题: Beta-secretase enzyme compositions and methods
-
申请号: US11090399申请日: 2005-03-25
-
公开(公告)号: US20050196839A1公开(公告)日: 2005-09-08
- 发明人: John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
- 申请人: John Anderson , Guriqbal Basi , Minh Doan , Normand Frigon , Varghese John , Michael Power , Sukanto Sinha , Gwen Tatsuno , Jay Tung , Shuwen Wang , Lisa McConlogue
- 申请人地址: US CA South San Francisco
- 专利权人: Elan Pharmaceuticals, Inc.
- 当前专利权人: Elan Pharmaceuticals, Inc.
- 当前专利权人地址: US CA South San Francisco
- 主分类号: A61K38/00
- IPC分类号: A61K38/00 ; C12N9/64 ; H01Q1/36 ; H01Q1/38 ; H01Q3/44 ; H01Q5/00 ; H01Q9/04 ; H01Q15/02 ; C07H21/04
摘要:
Disclosed are various forms of an active, isolated β-secretase enzyme in purified and recombinant form. This enzyme is implicated in the production of amyloid plaque components which accumulate in the brains of individuals afflicted with Alzheimer's disease. Recombinant cells that produce this enzyme either alone or in combination with some of its natural substrates (β-APPwt and β-APPsw) are also disclosed, as are antibodies directed to such proteins. These compositions are useful for use in methods of selecting compounds that modulate β-secretase. Inhibitors of β-secretase are implicated as therapeutics in the treatment of neurodegenerative diseases, such as Alzheimer's disease.
公开/授权文献
- US07262043B2 β-secretase enzyme compositions and methods 公开/授权日:2007-08-28
信息查询
IPC分类: